Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways

نویسندگان

چکیده

Iron has been proposed as influencing the progression of liver disease in subjects with non-alcoholic fatty (NAFLD). We have previously shown that, Hfe−/− mouse model hemochromatosis, feeding a high-calorie diet (HCD) leads to increased injury. In this study we investigated whether an iron deficient/HCD mice influenced development NAFLD. Liver histology was assessed fed standard iron-containing or iron-deficient plus minus HCD. Hepatic concentration, serum transferrin saturation and free acid were measured. Expression genes implicated regulation determined by quantitative real-time PCR (qRT-PCR). Standard iron/HCD-fed developed severe steatosis whereas NAS score reduced Mice HCD had lower weights, decreased ferroportin hepcidin gene expression than HCD-fed mice. Serum non-esterified acids compared analysis indicated that involved fatty-acid binding mTOR pathways regulated depletion. Our results indicate decreasing intake attenuates resulting from high calorie diet. These also suggest human studies agents modify balance patients NAFLD should be revisited.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Iron and non-alcoholic fatty liver disease

The mechanisms that promote liver injury in non-alcoholic fatty liver disease (NAFLD) are yet to be thoroughly elucidated. As such, effective treatment strategies are lacking and novel therapeutic targets are required. Iron has been widely implicated in the pathogenesis of NAFLD and represents a potential target for treatment. Relationships between serum ferritin concentration and NAFLD are not...

متن کامل

Outcome of Phlebotomy on Improvement of Liver Enzymes and Steatosis in Non-Alcoholic Fatty Liver Disease: A Randomized, Controlled Trial

Background and Objective: Iron overload in the liver can potentially induce non-alcoholic fatty liver disease (NAFLD). In this study, we sought to evaluate the phlebotomy in NAFLD, and compare it with modifiedlife style. Materials and Methods: This randomized, single-blind, clinical trial was carried out to evaluate the efficacy of phlebotomy on liver enzymes and steatosis in NAFLD patients. F...

متن کامل

Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease

Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...

متن کامل

The Effect of GeriLact on Non-Alcoholic Fatty Liver Disease

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease which is correlated with overweight, obesity, and insulin resistance. Recently, the use of probiotics has been suggested for these patients as they have considerable outcomes. The aim of the present study is to evaluate the effect of GeriLact on patients with NAFLD. Method:</...

متن کامل

The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial

Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymarin and vitamin E on patients with NAFLD. Materials and Methods: From September 2014 to March 201...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Biochimica Et Biophysica Acta: Molecular Basis Of Disease

سال: 2021

ISSN: ['0925-4439', '1879-260X']

DOI: https://doi.org/10.1016/j.bbadis.2021.166142